Singh, R. P., Franke, K.
, Kalucka, J., Mamlouk, S., Muschter, A., Gembarska, A., Grinenko, T., Willam, C., Naumann, R., Anastassiadis, K., Stewart, A. F., Bornstein, S., Chavakis, T., Breier, G., Waskow, C. & Wielockx, B. (2013).
HIF prolyl hydroxylase 2 (PHD2) is a critical regulator of hematopoietic stem cell maintenance during steady-state and stress.
Blood,
121(26), 5158-66.
https://doi.org/10.1182/blood-2012-12-471185Hermann, A., Loewenbrück, K. F., Boldt, Ä., Fiedler, C., Maisel, M.
, Kalucka, J., Schwarz, J., Breier, G. & Storch, A. (2013).
Lack of vascular endothelial growth factor receptor-2/Flk1 signaling does not affect substantia nigra development.
Neuroscience Letters,
553, 142-7.
https://doi.org/10.1016/j.neulet.2013.08.031Kalucka, J., Ettinger, A., Franke, K., Mamlouk, S., Singh, R. P., Farhat, K., Muschter, A., Olbrich, S., Breier, G., Katschinski, D. M., Huttner, W., Weidemann, A. & Wielockx, B. (2013).
Loss of epithelial hypoxia-inducible factor prolyl hydroxylase 2 accelerates skin wound healing in mice.
Molecular and Cellular Biology,
33(17), 3426-38.
https://doi.org/10.1128/MCB.00609-13
Klotzsche-von Ameln, A., Muschter, A., Mamlouk, S.
, Kalucka, J., Prade, I., Franke, K., Rezaei, M., Poitz, D. M., Breier, G. & Wielockx, B. (2011).
Inhibition of HIF prolyl hydroxylase-2 blocks tumor growth in mice through the antiproliferative activity of TGFβ.
Cancer Research,
71(9), 3306-16.
https://doi.org/10.1158/0008-5472.CAN-10-3838Drogat, B.
, Kalucka, J., Gutiérrez, L., Hammad, H., Goossens, S., Farhang Ghahremani, M., Bartunkova, S., Haigh, K., Deswarte, K., Nyabi, O., Naessens, M., Ferrara, N., Klingmüller, U., Lambrecht, B. N., Nagy, A., Philipsen, S. & Haigh, J. J. (2010).
Vegf regulates embryonic erythroid development through Gata1 modulation.
Blood,
116(12), 2141-51.
https://doi.org/10.1182/blood-2010-01-264143